Nattokinase vs Nattozimes: What's the Difference?
Aesthetics Advisor
JANUARY 7, 2024
In this clinical study ( Chen 2022 ) involving 1,062 participants, the objective was to examine the efficacy of NK (nattokinase) in atherosclerosis and hyperlipidemia and safety at the dose of 10,800 FU/day after 12 months of oral administration. This was reproduced in a similar study done by Oba and colleagues in 2021.
Let's personalize your content